Zhengbo Song

12PUBLICATIONS
40CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 05, 2024
Correction: The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.

Han Si, Xiaoshuang Fu, Yue Hao

|Jul 24, 2024
Rechallenge immunotherapy after immune resistance in patients with advanced thymic carcinoma.

Keda Shao, Xiaohong Zeng, Yue Hao

|Jul 24, 2024
The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumors.

Han Si, Xiaoshuang Fu, Yue Hao

|Apr 16, 2024
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations.

Yanhua Wang, Jingwen Wei, Manyi Xu

Pageof 2